What Goes Into An HIV Vaccine Trial?
Can you imagine a world free of HIV? Hanneke Schuitemaker, Ph.D., Vice President, Global Head of Viral Vaccine Discovery and Translational Medicine, Janssen Vaccines & Prevention B.V., can. She’s been working to help #makeHIVhistory for decades. Here, she shares her experience working on the Imbokodo study and Mosaico, a phase-3 efficacy study, and why she thinks we’ve never been so close to an efficacious HIV vaccine.
Read more...